Mal-β-Ala-PEG(4)-Val-Cit-PAB
CAS: 1949793-41-2
Ref. 3D-ZCD79341
| 1g | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado | ||
| 250mg | Descatalogado | ||
| 500mg | Descatalogado |
Información del producto
Nombre:
Mal-β-Ala-PEG(4)-Val-Cit-PAB
Descripción:
Mal-beta-Ala-PEG(4)-Val-Cit-PAB is a PEG linked peptide that belongs to the family of PEG products. It is a pegylated peptide that has been modified with polyethylene glycol (PEG) to enhance its stability and prolong its half-life in the body. This modification also helps to protect the peptide from degradation and improve its bioavailability. Mal-beta-Ala-PEG(4)-Val-Cit-PAB can be used in various applications, including drug delivery systems, diagnostics, and therapeutics. Its unique structure and properties make it an ideal choice for researchers and scientists working in the field of peptide-based therapies.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
777.9 g/mol
Fórmula:
C36H55N7O12
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
